Iguchi Kimi - Feb 3, 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
CFO & Treasurer
Signature
/s/ Anne Marie Cook, as Attorney-in-Fact for Kimi Iguchi
Stock symbol
SAGE
Transactions as of
Feb 3, 2023
Transactions value $
-$40,362
Form type
4
Date filed
2/7/2023, 03:10 PM
Previous filing
Jan 11, 2023
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Award $0 +2.85K +4.78% $0.00 62.5K Feb 3, 2023 Direct F1
transaction SAGE Common Stock Tax liability -$40.4K -914 -1.46% $44.16 61.6K Feb 3, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 10, 2021, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 9,500 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on February 3, 2023, resulting in the vesting of the PSUs as to 2,850 shares.